Related Experiment Video
Updated: Aug 12, 2026
06:51
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
[An alternative to postmenopausal Hormone Replacement Therapy? Selective Estrogens Receptors Modulators (SERMs)]
A Tinelli1, A Perrone, F G Tinelli
1Unità Operativa di Ostetricia e Ginecologia, Azienda Ospedaliera Vito Fazzi, Lecce, Italy. atinelli@freemail.it
Minerva Ginecologica
|April 25, 2001
Summary
Selective Estrogen Receptor Modulators (SERMs) offer a promising alternative to Hormone Replacement Therapy (HRT) for managing postmenopausal conditions. These compounds target estrogen receptors, providing a potentially safer treatment option with fewer adverse effects.
Area of Science:
- Endocrinology and Pharmacology
- Women's Health Research
Background:
- Hormone Replacement Therapy (HRT) is a primary treatment for postmenopausal disease.
- Adverse effects and risks associated with HRT necessitate alternative therapeutic strategies.
Purpose of the Study:
- To explore Selective Estrogen Receptor Modulators (SERMs) as a potential alternative to HRT.
- To evaluate the efficacy and safety profile of SERMs in managing postmenopausal conditions.
Main Methods:
- Review of pharmacological properties of SERMs.
- Analysis of SERMs' agonist/antagonist activity on estrogen receptors in target tissues.
- Comparison of SERMs' therapeutic potential against HRT.
Main Results:
- SERMs exhibit selective estrogen agonist/antagonist properties.
- These compounds interact with estrogen receptors in various tissues like bone, brain, and heart.
- SERMs demonstrate potential for diverse therapeutic actions.
Conclusions:
- SERMs represent a viable alternative to traditional HRT.
- The selective action of SERMs may offer a more targeted approach to postmenopausal disease management.
- Further research into SERMs is warranted to fully establish their role in clinical practice.
More Related Videos
Related Concept Videos
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...